852 related articles for article (PubMed ID: 33117804)
1. The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy.
Li G; Tian Y; Zhu WG
Front Cell Dev Biol; 2020; 8():576946. PubMed ID: 33117804
[TBL] [Abstract][Full Text] [Related]
2. The role of histone deacetylases in embryonic development.
Dsilva P; Pai P; Shetty MG; Babitha KS
Mol Reprod Dev; 2023 Jan; 90(1):14-26. PubMed ID: 36534913
[TBL] [Abstract][Full Text] [Related]
3. The emerging roles of HDACs and their therapeutic implications in cancer.
Hai R; Yang D; Zheng F; Wang W; Han X; Bode AM; Luo X
Eur J Pharmacol; 2022 Sep; 931():175216. PubMed ID: 35988787
[TBL] [Abstract][Full Text] [Related]
4. HDACs and HDAC Inhibitors in Cancer Development and Therapy.
Li Y; Seto E
Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27599530
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylases as targets in autoimmune and autoinflammatory diseases.
Hamminger P; Rica R; Ellmeier W
Adv Immunol; 2020; 147():1-59. PubMed ID: 32981634
[TBL] [Abstract][Full Text] [Related]
6. Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation.
Hutt DM; Roth DM; Marchal C; Bouchecareilh M
Methods Mol Biol; 2017; 1510():77-91. PubMed ID: 27761814
[TBL] [Abstract][Full Text] [Related]
7. Targeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implications.
Li Z; Zhu WG
Int J Biol Sci; 2014; 10(7):757-70. PubMed ID: 25013383
[TBL] [Abstract][Full Text] [Related]
8. HAT- and HDAC-Targeted Protein Acetylation in the Occurrence and Treatment of Epilepsy.
Wang J; Yun F; Sui J; Liang W; Shen D; Zhang Q
Biomedicines; 2022 Dec; 11(1):. PubMed ID: 36672596
[TBL] [Abstract][Full Text] [Related]
9. Roles of Histone Acetyltransferases and Deacetylases in the Retinal Development and Diseases.
Wang J; Feng S; Zhang Q; Qin H; Xu C; Fu X; Yan L; Zhao Y; Yao K
Mol Neurobiol; 2023 Apr; 60(4):2330-2354. PubMed ID: 36637745
[TBL] [Abstract][Full Text] [Related]
10. An Overview of HDAC Inhibitors and their Synthetic Routes.
Peng X; Liao G; Sun P; Yu Z; Chen J
Curr Top Med Chem; 2019; 19(12):1005-1040. PubMed ID: 30827245
[TBL] [Abstract][Full Text] [Related]
11. Prospects: histone deacetylase inhibitors.
Dokmanovic M; Marks PA
J Cell Biochem; 2005 Oct; 96(2):293-304. PubMed ID: 16088937
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy.
Ramaiah MJ; Tangutur AD; Manyam RR
Life Sci; 2021 Jul; 277():119504. PubMed ID: 33872660
[TBL] [Abstract][Full Text] [Related]
13. Nonhistone protein acetylation as cancer therapy targets.
Singh BN; Zhang G; Hwa YL; Li J; Dowdy SC; Jiang SW
Expert Rev Anticancer Ther; 2010 Jun; 10(6):935-54. PubMed ID: 20553216
[TBL] [Abstract][Full Text] [Related]
14. Natural Agents-Mediated Targeting of Histone Deacetylases.
Farooqi AA; Naqvi SK; Perk AA; Yanar O; Tabassum S; Ahmad MS; Mansoor Q; Ashry MS; Ismail M; Naoum GE; Arafat WO
Arch Immunol Ther Exp (Warsz); 2018 Feb; 66(1):31-44. PubMed ID: 28852775
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in class IIa histone deacetylases research.
Asfaha Y; Schrenk C; Alves Avelar LA; Hamacher A; Pflieger M; Kassack MU; Kurz T
Bioorg Med Chem; 2019 Nov; 27(22):115087. PubMed ID: 31561937
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors: mechanisms and clinical significance in cancer: HDAC inhibitor-induced apoptosis.
Shankar S; Srivastava RK
Adv Exp Med Biol; 2008; 615():261-98. PubMed ID: 18437899
[TBL] [Abstract][Full Text] [Related]
17. Individual histone deacetylases in Drosophila modulate transcription of distinct genes.
Cho Y; Griswold A; Campbell C; Min KT
Genomics; 2005 Nov; 86(5):606-17. PubMed ID: 16137856
[TBL] [Abstract][Full Text] [Related]
18. Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy.
Verza FA; Das U; Fachin AL; Dimmock JR; Marins M
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32585896
[TBL] [Abstract][Full Text] [Related]
19. Acetylation of proteins as novel target for antitumor therapy: review article.
Di Gennaro E; Bruzzese F; Caraglia M; Abruzzese A; Budillon A
Amino Acids; 2004 Jul; 26(4):435-41. PubMed ID: 15290351
[TBL] [Abstract][Full Text] [Related]
20. Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention.
Ruzic D; Djoković N; Srdić-Rajić T; Echeverria C; Nikolic K; Santibanez JF
Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
